Urgent Suspected Cancer
Policies
Biological and bioequivalent/biosimilar medicines
Mitomycin C bladder instillation following trans-urethral resection of bladder tumour (TURBT)
Needle biopsy of prostate in patients with suspected prostate cancer
Surveillance colonoscopy for patients after colorectal cancer resection or after colonic polypectomy
Surveillance colonoscopy for patients with hereditary increased risk of colorectal cancer
Pathways
Brain / CNS cancer
Breast cancer
Cancer of unknown primary (MUO)
Childhood cancer
ENT cancer
Gynaecological cancer
Haematological cancer
Investigation of possible ovarian cancer
Lower GI / colorectal cancer
Lung cancer
Malignant lymph nodes (below clavicle)
Maxillofacial / head and neck cancer
Metastatic spinal cord compression
Rapid Diagnostic Centre (vague symptoms)
Skin cancer
Suspected sarcoma-soft tissue / sarcoma-bone
Upper GI cancer
Urological cancer
Additional information
No additional information.